Thomson Medical Group Limited (SGX:A50)
0.0530
-0.0010 (-1.85%)
Sep 3, 2026, 1:37 PM SGT
Thomson Medical Group Ratios and Metrics
Market cap in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1,428 | 1,375 | 1,137 | 1,322 | 1,560 | 2,089 | |
Market Cap Growth | -8.47% | 20.94% | -14.00% | -15.25% | -25.32% | -8.14% |
Enterprise Value | 2,536 | 2,467 | 2,203 | 2,259 | 2,129 | 2,683 |
Last Close Price | 0.05 | 0.05 | 0.04 | 0.05 | 0.06 | 0.08 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | - | 93.39 | 42.68 | 38.85 |
Forward PE | 230.32 | 118.00 | 143.33 | 41.67 | - | - |
PS Ratio | 3.35 | 3.22 | 2.50 | 3.46 | 4.33 | 6.17 |
PB Ratio | 2.72 | 2.62 | 2.07 | 2.29 | 2.71 | 3.43 |
P/TBV Ratio | - | - | - | - | 87.67 | 43.87 |
P/FCF Ratio | 25.66 | 24.71 | 30.03 | 23.41 | 20.16 | 32.11 |
P/OCF Ratio | 20.12 | 19.38 | 18.81 | 15.86 | 17.61 | 22.51 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 5.95 | 5.78 | 4.84 | 5.90 | 5.91 | 7.93 |
EV/EBITDA Ratio | 32.54 | 35.98 | 18.25 | 23.99 | 22.31 | 26.06 |
EV/EBIT Ratio | 61.08 | 59.40 | 24.20 | 30.72 | 25.88 | 29.22 |
EV/FCF Ratio | 45.58 | 44.34 | 58.19 | 39.98 | 27.51 | 41.24 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 2.15 | 2.15 | 2.05 | 1.94 | 1.33 | 1.06 |
Debt / EBITDA Ratio | 14.50 | 14.50 | 8.65 | 11.01 | 7.46 | 5.88 |
Debt / FCF Ratio | 20.32 | 20.32 | 29.64 | 19.85 | 9.86 | 9.88 |
Net Debt / Equity Ratio | 1.95 | 1.95 | 1.84 | 1.68 | 0.82 | 0.80 |
Net Debt / EBITDA Ratio | 14.95 | 14.95 | 8.35 | 10.32 | 4.96 | 4.75 |
Net Debt / FCF Ratio | 18.43 | 18.43 | 26.63 | 17.19 | 6.12 | 7.52 |
Asset Turnover | 0.24 | 0.24 | 0.25 | 0.24 | 0.26 | 0.26 |
Inventory Turnover | 1.75 | 1.75 | 1.92 | 2.00 | 1.86 | 1.64 |
Quick Ratio | 0.54 | 0.54 | 0.64 | 0.66 | 2.90 | 0.62 |
Current Ratio | 1.04 | 1.04 | 1.19 | 1.09 | 3.67 | 0.95 |
Return on Equity (ROE) | -5.17% | -5.17% | -8.35% | 3.16% | 6.94% | 9.98% |
Return on Assets (ROA) | 1.46% | 1.46% | 3.17% | 2.82% | 3.66% | 4.33% |
Return on Invested Capital (ROIC) | 2.68% | 2.67% | 5.86% | 3.54% | 5.70% | 7.12% |
Return on Capital Employed (ROCE) | 2.80% | 2.80% | 6.00% | 4.80% | 6.20% | 8.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -2.08% | -2.16% | -4.18% | 1.07% | 2.34% | 2.57% |
FCF Yield | 3.90% | 4.05% | 3.33% | 4.27% | 4.96% | 3.11% |
Dividend Yield | - | - | - | - | 0.68% | - |
Buyback Yield / Dilution | -0.00% | -0.00% | 0.07% | -0.05% | -0.02% | 0.00% |
Total Shareholder Return | -0.00% | -0.00% | 0.07% | -0.05% | 0.66% | - |